Urora Pharmaceuticals Private Limited - Company Profile

It is a professional services private limited company based in Chennai, Tamil Nadu, India, established in 2018.

2018 Chennai, Tamil Nadu, India Active

Last Updated: February 09, 2026

About Urora Pharmaceuticals Private Limited

Urora Pharmaceuticals Private Limited, a active private limited company, was established on 17 May 2018 in Chennai, Tamil Nadu, India. Engaging in advocacy within the professional services sector, it holds CIN: U74110TN2018PTC122737. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Balu Iyyappan (Director), Iyyappan Vanithamani (Director). Its latest AGM occurred on 28 September 2019, with the balance sheet filed on 31 March 2019. It is based at No.53/45 Anna Street Chitlapakkam, Chennai, Tamil Nadu, 600064.

Company Details

CIN/LLPIN
U74110TN2018PTC122737
Registration Number
122737
Incorporation Date
17 May 2018
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 09-02-2026
Paid Up Capital ₹ 0.10 M as on 09-02-2026
Company Age 7 Year, 8 Months
Last Filing with ROC 31 Mar 2019

Comprehensive Company Insights

Explore comprehensive insights into Urora Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Urora Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Balu Iyyappan	Director	17 May 2018	Current
Iyyappan Vanithamani	Director	17 May 2018	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Urora Pharmaceuticals.

Urora Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Urora Pharmaceuticals?

Unlock access to Urora Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Urora Pharmaceuticals?

Unlock and access historical data on people associated with Urora Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Urora Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urora Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Urora Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Urora Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2019 as per latest MCA records. was documented.
28 Sep 2019
Balance Sheet

Urora Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was recorded as a recent event.
31 Mar 2019
Director Appointment

Progress on Balu Iyyappan was appointed as a Director was appointed as a Director on 17 May 2018 & has been associated with this company since 7 years 8 months . was documented.
17 May 2018
Director Appointment

Progress on Iyyappan Vanithamani was appointed as a Director was appointed as a Director on 17 May 2018 & has been associated with this company since 7 years 8 months . was documented.
17 May 2018
Company Incorporation

The activity Urora Pharmaceuticals Private Limited was registered on 17 May 2018 with Roc Chennai & aged 7 years 8 months as per MCA records. was completed.
17 May 2018

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Urora Pharmaceuticals Private Limited?

The CIN of Urora Pharmaceuticals Private Limited is U74110TN2018PTC122737.

Where is Urora Pharmaceuticals Private Limited headquartered?

Urora Pharmaceuticals Private Limited is headquartered at No.53/45 Anna Street Chitlapakkam, Chennai, Tamil Nadu, 600064.

When was Urora Pharmaceuticals Private Limited incorporated?

Urora Pharmaceuticals Private Limited was incorporated on 17 May 2018.

Who are the current directors of Urora Pharmaceuticals Private Limited?

The current directors of Urora Pharmaceuticals Private Limited are

What is the primary industry of Urora Pharmaceuticals Private Limited?

The primary industry of Urora Pharmaceuticals Private Limited is Professional Services.

Is Urora Pharmaceuticals Private Limited a listed company?

Urora Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Urora Pharmaceuticals Private Limited?

The authorized capital of Urora Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available